MIRM
Mirum Pharmaceuticals Inc
Price:  
44.10 
USD
Volume:  
574,465.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MIRM WACC - Weighted Average Cost of Capital

The WACC of Mirum Pharmaceuticals Inc (MIRM) is 8.1%.

The Cost of Equity of Mirum Pharmaceuticals Inc (MIRM) is 8.25%.
The Cost of Debt of Mirum Pharmaceuticals Inc (MIRM) is 7.00%.

Range Selected
Cost of equity 6.80% - 9.70% 8.25%
Tax rate -% - 0.30% 0.15%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.8% - 9.4% 8.1%
WACC

MIRM WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.64 0.87
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.80% 9.70%
Tax rate -% 0.30%
Debt/Equity ratio 0.14 0.14
Cost of debt 7.00% 7.00%
After-tax WACC 6.8% 9.4%
Selected WACC 8.1%